| Autor: |
Yamaguchi, Akio, Kurosaka, Yoshiyuki, Ishida, Tetsuya, Nishimura, Genichi, Kanno, Masahiro, Kosaka, Takeo, Yonemura, Yutaka, Miyazaki, Itsuo |
| Zdroj: |
Diseases of the Colon & Rectum; Oct1991, Vol. 34 Issue 10, p921-924, 4p |
| Abstrakt: |
We examined serum NCC-ST 439 for its significance as a tumor marker of large bowel cancer in 121 patients with primary and 36 with recurrent large bowel cancer. Serum NCC-ST 439 was positive in 27.3 percent of the former and 66.7 percent of the latter. It was false-positive in only 5.6 percent of patients with benign diseases. Positive serum NCC-ST 439 correlated with lymph node and liver metastases. The combination assay for NCC-ST 439, CEA, and CA19-9 was positive in 49.6 percent of the patients with primary tumors and 88.9 percent of those with recurrent tumors; in other words, the diagnostic accuracy improved. The results demonstrated that the determination of serum NCC-ST 439 in large bowel cancer might be useful in cancer staging and that NCC-ST 439, if used in combination with CEA, is particularly useful in diagnosing recurrences because of its improved diagnostic accuracy. [ABSTRACT FROM AUTHOR] |
| Databáze: |
Complementary Index |
| Externí odkaz: |
|
Full text from SpringerLink